Aquestive Therapeutics: Q3 Earnings Snapshot

WARREN, N.J. (AP) — WARREN, N.J. (AP) — Aquestive Therapeutics Inc. (AQST) on Monday reported a loss of $2 million in its third quarter.

The Warren, New Jersey-based company said it had a loss of 3 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The specialty pharmaceutical company posted revenue of $13 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $11.3 million.

Aquestive Therapeutics expects full-year revenue in the range of $47 million to $50 million.

In the final minutes of trading on Monday, the company's shares hit $1.63. A year ago, they were trading at 88 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST